← All trials
NCT06381570
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 21, 2024
- Primary completion
- Mar 21, 2026
- Completion date
- Mar 21, 2029
- First posted
- Apr 24, 2024
- Last posted
- Apr 24, 2024
- Enrollment
- 57
- Arms / groups
- — / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of TorontoLead sponsor
- University of TorontoSponsor investigator
- University of TorontoCollaborator
- University of TorontoOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.